Terpenes with antifungal activity against malassezia yeasts

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/336 (2006.01) A61P 17/00 (2006.01) A61P 17/06 (2006.01) A61P 17/08 (2006.01) A61P 31/10 (2006.01)

Patent

CA 2689212

The present invention relates to the use of some terpenes, for example chlovalicin, ovalicin or fumagillin, as antifungal against Malassezia species and to their use in the manufacture of medicaments for the treatment of human skin diseases caused by these Malassezia species, such as pityriasis versicolor, seborrheic dermatitis, dandruff, atopic dermatitis, psoriasis, confluent and reticulated papillomatosis, onychomycosis, and transient acantholytic dermatosis.

La présente invention concerne l'utilisation de certains terpènes, tels que la chlovalicine, l'ovalicine ou la fumagilline, comme agent antifongique dirigé contre les espèces du genre Malassezia et leur utilisation dans la fabrication de médicaments destinés au traitement de maladies humaines de la peau provoquées par ces espèces du genre Malassezia, telles que le pityriasis versicolor, la dermatite séborrhéique, les pellicules, la dermatite atopique, le psoriasis, la papillomatose confluente et réticulée, l'onychomycose, et la dermatose acantholytique transitoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Terpenes with antifungal activity against malassezia yeasts does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Terpenes with antifungal activity against malassezia yeasts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Terpenes with antifungal activity against malassezia yeasts will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1616622

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.